Clinical Trial Update: Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults [Phase 1]

View source ↗

Summary

Completion of a Phase 1 safety and pharmacokinetics study of single ascending doses of CVT-427 (zolmitriptan inhalation powder) in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• CVT-427 (Zolmitriptan Inhalation Powder) (zolmitriptan inhalation powder)

Snippet

Sponsor: Acorda Therapeutics | Conditions: Migraine | Phase 1 | Status: COMPLETED